You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 24, 2024

Roche Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for ROCHE, and what generic and branded alternatives to ROCHE drugs are available?

ROCHE has sixty-one approved drugs.

Summary for Roche

US Patents:	0
Tradenames:	49
Ingredients:	45
NDAs:	61
Patent Litigation for Roche:	See patent lawsuits for Roche

Drugs and US Patents for Roche

+ Get email alerts for changes to this table

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Roche Palo	CYTOVENE	ganciclovir	CAPSULE;ORAL	020460-002	Dec 12, 1997		DISCN	Yes	No		⤷ Subscribe				⤷ Subscribe
Roche	HIVID	zalcitabine	TABLET;ORAL	020199-001	Jun 19, 1992		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Roche	TRIMPEX 200	trimethoprim	TABLET;ORAL	017952-002	Nov 9, 1982		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Roche

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Roche	LARIAM	mefloquine hydrochloride	TABLET;ORAL	019591-001	May 2, 1989	4,579,855	⤷ Subscribe
Roche Palo	FEMSTAT	butoconazole nitrate	CREAM;VAGINAL	019215-001	Nov 25, 1985	4,078,071	⤷ Subscribe
Roche	KLONOPIN RAPIDLY DISINTEGRATING	clonazepam	TABLET, ORALLY DISINTEGRATING;ORAL	020813-004	Dec 23, 1997	4,758,598	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Paragraph IV (Patent) Challenges for ROCHE drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Oral Suspension	6 mg/mL	➤ Subscribe	2015-06-18
➤ Subscribe	Injection	1 mg/mL, 1 mL vials	➤ Subscribe	2004-06-01
➤ Subscribe	Injection	1 mg/mL, 3 mL Vial	➤ Subscribe	2007-08-31
➤ Subscribe	For Oral Suspension	200 mg/mL	➤ Subscribe	2011-03-25
➤ Subscribe	Capsules	30 mg and 45 mg	➤ Subscribe	2011-08-02
➤ Subscribe	Injection	0.1 mg/mL, 1 mL single dose vial	➤ Subscribe	2007-03-08
➤ Subscribe	Injection	1 mg/mL, 4 mL multi-dose vials	➤ Subscribe	2004-07-19
➤ Subscribe	Tablets	2.5 mg and 150 mg	➤ Subscribe	2007-05-16
➤ Subscribe	Capsule	75 mg	➤ Subscribe	2010-11-15

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.